Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration

Overview of attention for article published in Clinical Ophthalmology, July 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 2,784 followers.

Twelve-week dosing with Aflibercept in the treatment of neovascular #AMD | #ECM https://t.co/irTdRev6IR

Twelve-week dosing with Aflibercept in the treatment of neovascular #AMD | #ECM https://t.co/irTdRev6IR

Ophthopedia Update: Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration https://t.co/W1H4ohMA38 #Ophthomology #Eye #Ophthotwitter